Page last updated: 2024-11-04

sulfinpyrazone and Osteoporosis

sulfinpyrazone has been researched along with Osteoporosis in 1 studies

Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.

Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Motawakel, AG1

Other Studies

1 other study available for sulfinpyrazone and Osteoporosis

ArticleYear
[Gout in dermatology].
    Zeitschrift fur Haut- und Geschlechtskrankheiten, 1969, Oct-15, Volume: 44, Issue:20

    Topics: Adolescent; Aged; Colchicine; Diagnosis, Differential; Gout; Humans; Indomethacin; Joint Diseases; M

1969